Pharmacochaperoning of the A1 adenosine receptor is contingent on the endoplasmic reticulum

Molecular Pharmacology

Volumn 77, Issue 6, 2010, Pages 940-952

  Málaga Diéguez, Laura ^a   Yang, Qiong ^a   Bauer, Jan ^a   Pankevych, Halyna ^a   Freissmuth, Michael ^a   Nanoff, Christian ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; CHAPERONE; D1 RECEPTOR INTERACTING PROTEIN 78; HEAT SHOCK PROTEIN; ISOBUTYLMETHYLXANTHINE; TUNICAMYCIN; UNCLASSIFIED DRUG; GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND;

ALPHA HELIX; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; EMBRYO; ENDOPLASMIC RETICULUM; GENE MUTATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; ANIMAL; CELL LINE; DRUG EFFECT; GENETICS; METABOLISM; MUTAGENESIS; MUTATION;

ANIMALS; CELL LINE; CELL MEMBRANE; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; GTP-BINDING PROTEINS; HUMANS; LIGANDS; MOLECULAR CHAPERONES; MUTAGENESIS; MUTATION; RATS; RECEPTOR, ADENOSINE A1; TUNICAMYCIN;

EID: 77952333017     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.063511     Document Type: Article

References (37)

1. Alewijnse AE, Timmerman H, Jacobs EH, Smit MJ, Roovers E, Cotecchia S, and Leurs R (2000) The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor. Mol Pharmacol 57:890-898. (Pubitemid 30253371)
2. Bermak JC, Li M, Bullock C, and Zhou QY (2001) Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein. Nat Cell Biol 3:492-498. (Pubitemid 32422085)
3. Chaipatikul V, Erickson-Herbrandson LJ, Loh HH, and Law PY (2003) Rescuing the traffic-deficient mutants of rat μ-opioid receptors with hydrophobic ligands. Mol Pharmacol 64:32-41. (Pubitemid 36759815)
4. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, et al. (2007) High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor. Science 318:1258-1265.
5. Citterio C, Vichi A, Pacheco-Rodriguez G, Aponte AM, Moss J, and Vaughan M (2008) Unfolded protein response and cell death after depletion of brefeldin A-inhibited guanine nucleotide-exchange protein GBF1 Proc Natl Acad Sci USA 105:2877-2882.
6. Conn PM, Knollman PE, Brothers SP, and Janovick JA (2006) Protein folding as posttranslational regulation: evolution of a mechanism for controlled plasma membrane expression of a G protein-coupled receptor. Mol Endocrinol 20:3035-3041.
7. Delos Santos NM, Gardner LA, White SW, and Bahouth SW (2006) Characterization of the residues in helix 8 of the human β1-adrenergic receptor that are involved in coupling the receptor to G proteins. J Biol Chem 281:12896-12907.
8. Duvernay MT, Zhou F, and Wu G (2004) A conserved motif for the transport of G protein-coupled receptors from the endoplasmic reticulum to the cell surface. J Biol Chem 279:30741-30750. (Pubitemid 38938007)
9. Duvernay MT, Dong C, Zhang X, Zhou F, Nichols CD, and Wu G (2009) Anterograde trafficking of G protein-coupled receptors: function of the C-terminal F(X)6LL motif in export from the endoplasmic reticulum. Mol Pharmacol 75:751-761.
10. Fan J, Perry SJ, Gao Y, Schwarz DA, and Maki RA (2005) A point mutation in the human melanin concentrating hormone receptor 1 reveals an important domain for cellular trafficking. Mol Endocrinol 19:2579-2590. (Pubitemid 41362670)
11. Fritze O, Filipek S, Kuksa V, Palczewski K, Hofmann KP, and Ernst OP (2003) Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation. Proc Natl Acad Sci USA 100:2290-2295.
12. Gáborik Z, Mihalik B, Jayadev S, Jagadeesh G, Catt KJ, and Hunyady L (1998) Requirement of membrane-proximal amino acids in the carboxyl-terminal tail for expression of the rat AT1a angiotensin receptor. FEBS Lett 428:147-151. (Pubitemid 28319674)
13. Hawtin SR (2006) Pharmacological chaperone activity of SR49059 to functionally recover misfolded mutations of the vasopressin V1a receptor. J Biol Chem 281:14604-14614.
14. Huyer G, Piluek WF, Fansler Z, Kreft SG, Hochstrasser M, Brodsky JL, and Michaelis S (2004) Distinct machinery is required in Saccharomyces cerevisiae for the endoplasmic reticulum-associated degradation of a multispanning membrane protein and a soluble luminal protein. J Biol Chem 279:38369-38378.
15. Jockers R, Linder ME, Hohenegger M, Nanoff C, Bertin B, Strosberg AD, Marullo S, and Freissmuth M (1994) Species difference in the G protein selectivity of the human and bovine A1 adenosine receptor. J Biol Chem 269:32077-32084.
16. Kanehara K, Kawaguchi S, and Ng DT (2007) The EDEM and Yos9p families of lectin-like ERAD factors. Semin Cell Dev Biol 18:743-750. (Pubitemid 350138449)
17. Klinger M, Freissmuth M, and Nanoff C (2002) Adenosine receptors: G protein-mediated signalling and the role of accessory proteins. Cell Signal 14:99-108. (Pubitemid 34056581)
18. Kuge O, Dascher C, Orci L, Rowe T, Amherdt M, Plutner H, Ravazzola M, Tanigawa G, Rothman JE, and Balch WE (1994) Sar1 promotes vesicle budding from the endoplasmic reticulum but not Golgi compartments. J Cell Biol 125:51-65. (Pubitemid 24983349)
19. Leskelä TT, Markkanen PM, Pietilä EM, Tuusa JT, and Petäjä-Repo UE (2007) Opioid receptor pharmacological chaperones act by binding and stabilizing newly synthesized receptors in the endoplasmic reticulum. J Biol Chem 282:23171-23183.
20. Li Q, Lau A, Morris TJ, Guo L, Fordyce CB, and Stanley EF (2004) A syntaxin 1, Gα(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization. J Neurosci 24:4070-4081. (Pubitemid 38544233)
21. Mizrachi D and Segaloff DL (2004) Intracellularly located misfolded glycoprotein hormone receptors associate with different chaperone proteins than their cognate wild-type receptors. Mol Endocrinol 18:1768-1777.
22. Morello JP, Salahpour A, Laperrière A, Bernier V, Arthus MF, Lonergan M, Petäjä-Repo U, Angers S, Morin D, Bichet DG, et al. (2000) Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 105:887-895.
23. Morello JP, Salahpour A, Petäjä-Repo UE, Laperrière A, Lonergan M, Arthus MF, Nabi IR, Bichet DG, and Bouvier M (2001) Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus. Biochemistry 40:6766-6775.
24. Noorwez SM, Kuksa V, Imanishi Y, Zhu L, Filipek S, Palczewski K, and Kaushal S (2003) Pharmacological chaperone-mediated in vivo folding and stabilization of the P23H-opsin mutant associated with autosomal dominant retinitis pigmentosa. J Biol Chem 278:14442-14450.
25. Oksche A, Dehe M, Schülein R, Wiesner B, and Rosenthal W (1998) Folding and cell surface expression of the vasopressin V2 receptor: requirement of the intracellular C-terminus. FEBS Lett 424:57-62. (Pubitemid 28130352)
26. Pankevych H, Korkhov V, Freissmuth M, and Nanoff C (2003) Truncation of the A1 adenosine receptor reveals distinct roles of the membrane-proximal carboxyl terminus in receptor folding and G protein coupling. J Biol Chem 278:30283-30293.
27. Petäjä-Repo UE, Hogue M, Bhalla S, Laperrière A, Morello JP, and Bouvier M (2002) Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. EMBO J 21:1628-1637. (Pubitemid 34614619)
28. 6-phenylisopropyladenosine. Biochem Pharmacol 33:1783-1788.
29. Prioleau C, Visiers I, Ebersole BJ, Weinstein H, and Sealfon SC (2002) Conserved helix 7 tyrosine acts as a multistate conformational switch in the 5HT2C receptor. Identification of a novel "locked-on" phenotype and double revertant mutations. J Biol Chem 277:36577-36584.
30. Qiu XB, Shao YM, Miao S, and Wang L (2006) The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones. Cell Mol Life Sci 63:2560-2570. (Pubitemid 44800711)
31. Robert J, Clauser E, Petit PX, and Ventura MA (2005a) A novel C-terminal motif is necessary for the export of the vasopressin V1b/V3 receptor to the plasma membrane. J Biol Chem 280:2300-2308.
32. Robert J, Auzan C, Ventura MA, and Clauser E (2005b) Mechanisms of cell-surface rerouting of an endoplasmic reticulum-retained mutant of the vasopressin V1b/V3 receptor by a pharmacological chaperone. J Biol Chem 280:42198-42206. (Pubitemid 43023190)
33. Sawyer GW, Ehlert FJ, and Shults CA (2010) A conserved motif in the membrane proximal C-terminal tail of human muscarinic m1 acetylcholine receptors affects plasma membrane expression. J Pharmacol Exp Ther 332:76-86.
34. Thielen A, Oueslati M, Hermosilla R, Krause G, Oksche A, Rosenthal W, and Schülein R (2005) The hydrophobic amino acid residues in the membrane-proximal C tail of the G protein-coupled vasopressin V2 receptor are necessary for transport-competent receptor folding. FEBS Lett 579:5227-5235. (Pubitemid 41318096)
35. Urizar E, Claeysen S, Deupí X, Govaerts C, Costagliola S, Vassart G, and Pardo L (2005) An activation switch in the rhodopsin family of G protein-coupled receptors: the thyrotropin receptor. J Biol Chem 280:17135-17141. (Pubitemid 41389178)
36. Van Craenenbroeck K, Clark SD, Cox MJ, Oak JN, Liu F, and Van Tol HH (2005) Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis. J Biol Chem 280:19350-19357.
37. Wüller S, Wiesner B, Löffler A, Furkert J, Krause G, Hermosilla R, Schaefer M, Schülein R, Rosenthal W, and Oksche A (2004) Pharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors. J Biol Chem 279:47254-47263.